iShares Biotechnology ETF $IBB Holdings Lowered by Texas Yale Capital Corp.

Texas Yale Capital Corp. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 19.9% in the second quarter, HoldingsChannel reports. The fund owned 12,840 shares of the financial services provider’s stock after selling 3,192 shares during the quarter. Texas Yale Capital Corp.’s holdings in iShares Biotechnology ETF were worth $1,624,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Ramirez Asset Management Inc. bought a new stake in iShares Biotechnology ETF during the first quarter worth approximately $26,000. Berkshire Money Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $28,000. Financial Gravity Asset Management Inc. acquired a new position in shares of iShares Biotechnology ETF during the 1st quarter valued at $30,000. Woodside Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the 1st quarter worth $31,000. Finally, Harbor Asset Planning Inc. acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at $31,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.4%

Shares of IBB stock opened at $157.72 on Friday. The stock has a 50-day simple moving average of $148.73 and a 200 day simple moving average of $135.55. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $159.79.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $0.33 annualized dividend and a dividend yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.